Progress of early prediction methods for refractory Mycoplasma pneumoniae pneumonia in children

VernacularTitle:儿童难治性肺炎支原体肺炎早期预测方法的研究进展
Author: Shuai LIU ¹ ; Hong LIU
Author Information

1. 江西省儿童医院急诊医学科，南昌　330006南昌大学江西医学院　330031
Keywords: Children; Refractory Mycoplasma pneumoniae pneumonia; Early prediction; Biomarker
From: International Journal of Pediatrics 2024;51(3):174-178
CountryChina
Language:Chinese
Abstract: Mycoplasma pneumoniae is one of the main pathogen of community-acquired pneumonia in children in China. Although most children with Mycoplasma pneumoniae pneumonia have a good prognosis，a small number of children can progress to refractory Mycoplasma pneumoniae pneumonia. Compared with general mycoplasma pneumoniae pneumonia，the clinical symptoms and lung imaging findings of refractory Mycoplasma pneumoniae pneumonia are more serious. Fever and treatment time are longer and extrapulmonary complications are more likely to occur. In order to better identify and treat refractory Mycoplasma pneumoniae pneumonia at an early stage，some scholars have carried out studies on early prediction of refractory Mycoplasma pneumoniae pneumonia by using biomarkers，imaging findings and nomogram. This paper reviews relevant studies in recent years，to provide reference for early prediction of refractory Mycoplasma pneumoniae pneumonia.